Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion Ke-Xun YuWei-Jie YuanYong-Xiang Li Review Open access 02 May 2024 Article: 115
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms Bence FerenczKlára TörökBalázs Döme Research Open access 02 May 2024 Article: 114
Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells Gabriele FavarettoMarianna Nicoletta RossiFabrizio Antonangeli Research Open access 02 May 2024 Article: 113
New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model Dajun YuJie YangChao Zhu Research Open access 02 May 2024 Article: 112
Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer Yadong WangZhicheng HuangNaixin Liang Research Open access 26 April 2024 Article: 111
Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation Graziela PerriVanessa Garcia Vilas BoasAna Paula Campanelli Research Open access 25 April 2024 Article: 110
Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study Sara MaherHesham A. ElmeligyManal Kamel Research Open access 25 April 2024 Article: 109
A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis Qingyang LeiShanshan ZhenYi Zhang Research Open access 20 April 2024 Article: 108
A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma Jing XuWen ZhangJie Ma Research Open access 20 April 2024 Article: 107
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study Francesco MassariMatteo SantoniJoaquim Bellmunt Research Open access 18 April 2024 Article: 106
Correction to: Dominant‑negative transforming growth factor‑β receptor‑armoured mesothelin‑targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer Ke LiJing XuYu Kang Correction Open access 18 April 2024 Article: 105
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia Sha MaYing WangKailin Xu Research Open access 17 April 2024 Article: 104
Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma Lanqun QinGuiying ZhangZhengyun Zou Research Open access 17 April 2024 Article: 103
TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming Junseok LeeKeon-Il ImSeok-Goo Cho Research Open access 17 April 2024 Article: 102
Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy Sangjoon ChoiMofazzal HossainHee Jin Lee Research Open access 17 April 2024 Article: 101
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma Sophia StockLuisa FertigSebastian Kobold Research Open access 17 April 2024 Article: 100
T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC Ling YiZiwei XuYi Han Research Open access 15 April 2024 Article: 99
Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma Nithidol SakunrangsitNattarika KhuisangeamSupannikar Tawinwung Research Open access 15 April 2024 Article: 98
Integrating bulk and single-cell sequencing data to construct a Scissor+ dendritic cells prognostic model for predicting prognosis and immune responses in ESCC Maosheng ChengJianqi XiongShuang Chen Research Open access 15 April 2024 Article: 97
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival Jessica WedigShrina JasaniThomas A. Mace Research Open access 15 April 2024 Article: 96